BioSpace News Archive

Policy

Operation Warp Speed Selects McKesson for COVID-19 Vaccine Distribution

“Today’s announcement puts another building block in place as the Nation moves toward a safe and effective COVID-19 vaccine,” stated Robert Redfield, director of the U.S. Centers for Disease Control and Prevention.

August 17, 2020
·
3 min read
·
Mark Terry
Deals

Sanofi Acquires Principia Biopharma in $3.6 Billion Deal

Under terms of the deal, Sanofi will acquire all of the outstanding shares of Principia for $100 per share in cash, which represents an aggregate equity value of approximately $3.68 billion.

August 17, 2020
·
3 min read
·
Alex Keown
Drug Development

Unity Bio’s Pain Drug Flunks Phase II Arthritis Trial

UNITY Biotechnology reported that the 12-week results from its Phase II study of UBX0101 in moderate-to-severe painful osteoarthritis (OA) of the knee failed to show improvement over placebo.

August 17, 2020
·
3 min read
·
Mark Terry
Policy

Biopharma Update on the Novel Coronavirus: August 19

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 19, 2020.

August 17, 2020
·
2 min read
·
BioSpace Editorial Staff
FDA

FDA Approves Genentech’s Enspryng for Neuromyelitis Optica Spectrum Disorder

The U.S. Food and Drug Administration approved Genentech’s Enspryng (satralizumab-mwge) as a subcutaneous treatment for adults with anti-aquaporin-4 (AQP4) antibody positive neuromyelitis optica spectrum disorder.

August 17, 2020
·
3 min read
·
Mark Terry
Business

In the Midst of Pandemic, Top HHS and CDC Officials Resign

In the midst of an international pandemic, three high-profile public health officials are leaving government service.

August 17, 2020
·
2 min read
·
Alex Keown
Drug Development

Biotech Startup Codagenix Plans Human Trials for COVID-19 Vaccine

The 11-person team at Codagenix may be tiny, but it has big plans for the company’s new COVID-19 vaccine.

August 17, 2020
·
5 min read
·
Brianna Sleezer
Policy

Biopharma Update on the Novel Coronavirus: August 17

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 17, 2020.

August 17, 2020
·
2 min read
·
BioSpace Editorial Staff
Genetown

BMS Licenses IL-12 from Dragonfly in $475 Million Deal

Bristol Myers Squibb plunked down $475 million for the exclusive license to Dragonfly Therapeutics’ interleukin-12 (IL-12) investigational immunotherapy program.

August 17, 2020
·
3 min read
·
Alex Keown
Drug Development

OSE Immunotherapeutics Publishes Positive Preclinical COVID-19 Vaccine Results With Multi-Target Vaccine CoVepiT

Data support potential as novel and differentiated COVID-19 vaccine designed against multiple SARS-CoV-2targets with technology known to induce memory T lymphocytes

August 17, 2020
·
8 min read